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Obituary 
Peter Hemmerich, 1929-1981 
With the death of Peter Hemmerich at the 
age of 51 on October 3, 1981, a restless life, 
full of search for fulfillment, full of ideas 
and achievement, but also of feuds and 
skirmishes, has come to an untimely end. 
With him the initiator and most forceful and 
vocal exponent of the second era of flavin 
research- the present day era as opposed to 
that of the thirties - has passed away. It is 
probably fair to say that had it not been for 
his relentless quest into so many aspects of 
flavin chemistry, his keen interest in seeing 
the knowledge thus gained related to flavin 
function in enzymes, and to his uncom- 
promising demand for rigor in doing so our 
understanding of flavin chemistry and func- 
tion in catalysis would be lagging behind by 
one or more decades. 
Peter Hemmerich was born in Frankfurt 
am Main, the elder son of a well-to-do mer- 
chant family, on December 30, 1929. With 
the shortage of places in German univer- 
sities in the post-war years, he was not able 
to find a place as a student of chemistry, and 
so enrolled at the University of Freiburg in 
1948 in the mathematics curriculum. With 
financial aid from an uncle, he transferred 
the next year to the University of Basel 
where, a few years later, he entered the pre- 
stigious Institute of Inorganic Chemistry as 
a Ph.D. student of Hans Erlenmeyer. 
Erlenmeyer was an authority in the chemis- 
try of metal chelates and apparently had 
some intuition that the function of metals in 
biological materials might be related to 
their chelate chemistry. Those happened to 
be the years (the early fifties) when the idea 
sprung up, with some apparent experimen- 
tal support, that riboflavin was a metal 
chelator and that some of its biological 
functions could be explained by that prop- 
erty. This became of particular interest, 
when just then metals were discovered as 
constituents of a number of flavoproteins 
such as succinate and NADH dehydrogen- 
ases or xanthine oxidase. Erlenmeyer, 
therefore, suggested to Hemmerich that he 
look into the chelating ability of riboflavin. 
Hemmerich soon became frustrated by 
the limited solubility of riboflavin and 
known isoalloxazine derivatives; thus he 
decided on the bold strategy of replacing 
the oxygen at the flavin 2 a-position by sul- 
fur and of alkylating this, the N(3)-H and 
the C(4)-a position with various sub- 
stituents. The resulting flavins, achieved by 
new and more efficient synthetic routes, 
were the product of the first original 
research of Peter Hemmerich (largely pub- 
lished in Helvetica Chimica Acta ). In the 
course of this brilliant research he estab- 
lished the structure of flavin, that we are 
now so used to seeing, as the 2,4- 
dicarbonyl tautomer A, rather than the 
iminohydroxyl tautomer B, which used to 
be seen frequently (and occasionally still is) 
in biochemistry texts. The period at Basel 
also involved studies on the chelation abil- 
ity of riboflavin. Hemmerich's first paper 
on this subject (Helv. Chim. Acta 
(1958) 41,498) with S. Fallab decisively 
dampened the enthusiasm that had arisen 
Peter Ifernmerich 
about that subject; he showed that oxidized 
flavin had only weak chelator properties 
and that metal chelation was a property only 
for the flavin radical. This finding, how- 
ever, had several important consequences. 
It helped in the recognition that the metals 
were parts of discrete redox centers and not 
directly liganded to the flavin. It also led 
naturally to his decisive studies on the prop- 
erties of flavin radicals. 
His work soon came to the attention of 
the biochemical community and resulted in 
close international collaborations with a 
number of biochemical colleagues, includ- 
ing Anders Ehrenberg in Stockholm, Cees 
Veeger in Wageningen, Thomas P. Singer 
in San Francisco and ourselves. Several of 
these have spanned many years, from his 
first visits to the U.S.A. in 1964 and 1965, 
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right up to his death. Indeed in the earlier 
years he remarked on occasion that he had 
to travel abroad to find out that there were 
actually people interested in what he was 
doing. Hemmerich's collaborations origi- 
nated from his desire to relate his funda- 
mental chemical studies to the biological 
roles of flavins, for he was among the first 
to realize the great chemical versatility of 
flavins and that not every model chemical 
reaction necessarily pointed the way to the 
mechanism of a particular enzymic reac- 
tion. He was also quick to seize on correla- 
tions of properties of particular flavopro- 
reins and the types of reactions which they 
catalyzed. Because of his impatience to fer- 
ret out the order which he believed must 
exist in nature, he occasionally made pre- 
mature judgments and interpretations 
which proved misleading or confusing. 
However, even in those cases where it 
turned out that he was wrong, his catalytic 
influence on experimentation and discus- 
sion in the field was of great importance. 
His belief that different classes of flavopro- 
teins must have different protein structural 
elements, but with common structural fea- 
tures within each class, led to the more 
rational classification scheme for flavoen- 
zymes which he developed in his last years. 
It was indeed these principles of order that 
he saw through the thicket of specialized 
information on some several hundred 
flavoproteins which occupied his mind 
most up to his last days. He impressed upon 
his friends the need to continue his quest 
into this problem and verify and consolidate 
his ideas should he fall victim to his disease. 
His scientific output was prolific. In the 
25 years of his career, he published with stu- 
dents and colleagues 170 research papers 
and reviews. In addition' to those already 
mentioned, other highlights of his research 
career include the realization of the ease of 
formation of covalent adducts of flavins 
and their possible participation in catalysis, 
fundamental investigations and practical 
applications of ravin photochemistry, the 
determination of properties of flavins in the 
reduced state, and participation in the 
elucidation of the structure of flavins coval- 
ently linked to proteins. Hemmerich's 
intense interest and love of ravin research 
have been passed on to several students and 
younger colleagues. Notable among these 
are Franz Mfiller (Wageningen) and Sandro 
Ghisla (Konstanz). 
Hemmerich was also keenly interested in 
the structure and function of catalytic 
groups in enzymes operating in conjunction 
with flavins such as the iron sulfur clusters 
or molybdenum, and in copper proteins. 
Iron-sulfur clusters were first recognized in 
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Fig. 1. Possible tautomers o f  flavin. (A ) 2,4-dicarbonyl. ( B) iminohydroxyl. 
course, not known initially. Hemmerich 
was among the first to show that iron- 
complexes, contrary to general opinion, 
could have EPR resonances with properties 
similar to the observed unknowns. He also 
strongly suggested to biochemists to con- 
sider sulfur ligands to copper in copper pro- 
teins and pointed out the resulting 
ambiguity in the valency of the copper in 
such systems. He always kept in his 
laboratory a research group active in the 
field of copper and molybdenum model 
complexes, work which more recently has 
been pursued and extended by Peter 
Kroneck (Konstanz), partially in collabora- 
tion with Jack Spence (Utah). 
The decisive event in his career occurred 
in 1967 when the newly founded University 
of Konstanz tried to assemble a diversified 
biology faculty. Max Delbrtick, who 
advised the founding rector, drew his atten- 
tion to Hemmerich's work which was striv- 
ing toward a synthesis of biological, 
organic and inorganic chemistry. Thus 
Hemmerich became one of the first mem- 
hers of that faculty. He stayed at Konstanz 
for the rest of his life, establishing a flou- 
rishing research group devoted to the study 
of flavins as well as a group working with 
copper proteins. Konstanz quickly became 
a world-renowned center for flavin 
research. 
Peter Hemmerich was an enthusiastic 
hiker, skier, sailor and hunter; however, 
being the man he was, he would not pursue 
these activities in conventional ways but at 
the border of what others may have found 
exhausting or even dangerous, lie was one 
of those personalities who rarely left people 
unimpressed - in a positive or in a negative 
sense - wherever he became involved. He 
cared strongly about many things; about 
science, education, his friends, and the 
environment, particularly about his beloved 
Bodensee (Lake Constance) and to further 
these aims he became a member of the 
Konstanz City Council. He also wrote vol- 
uminously and wittily for Die Zeit, a prom- 
inent German cultural and political weekly. 
For those who were close to Hemmerich, 
life will have become more calm; but it may 
also have lost some of its more vivid colors. 
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The Ludwig Institute for Cancer 
Research 
Carl G. Baker 
The Ludwig Institute for Cancer Research 
was established in 1971 as a charitable, 
international medical research organization 
devoted exclusively to the investigation of 
cancer for the benefit of the public. The 
Institute is not a foundation and does not 
award grants. Rather, it has established 
Branches that are direct operating com- 
ponents of the Institute located in different 
parts of the world. The Institute's research 
is conducted through these Branches in con- 
junction with hospitals that are themselves 
organized and operated exclusively for 
animal tissues by their unusual EPR sig- Carl G. Baker is at the Ludwig Institute for Cancer 
nals. The origin of these signals was, of Research, 8001 Zurich, Switzerland. 
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charitable purposes. The Institute pays for 
the total cost of the research. Selection of 
the location of the Branches is influenced 
by the prospects for conducting outstanding 
clinical and laboratory research in the con- 
text of a well established research environ- 
ment (hospitals, universities and research 
institutes). 
The Institute's income is derived from an 
endowment consisting of assets contributed 
by Mr Daniel K. Ludwig. The Institute 
qualifies as a charitable institution in 
Switzerland, the United States, England, 
Australia, Belgium and Canada. Because 
of its central location and economic and 
political stability Switzerland was chosen 
